ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Vor Biopharma Inc

Vor Biopharma Inc (VOR)

1,11
0,00
(0,00%)
Fermé 02 Janvier 10:00PM
0,00
0,00
(0,00%)
Après les heures de négociation: -

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
1,11
Prix Achat
1,07
Prix Vente
1,10
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,6354 Plage de 52 semaines 3,1399
Cap du marché
Clôture Veille
1,11
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
656 592
Actions en circulation
68 673 612
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,64
Bénéfice par action (BPA)
-1,72
Chiffre d'affairess
-
Bénéfice net
-117,86M

À propos de Vor Biopharma Inc

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33. Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
-
Vor Biopharma Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker VOR. Le dernier cours de clôture d'Vor Biopharma était de US$1,11. Au cours de la dernière année, les actions de Vor Biopharma ont été négociées dans une fourchette de prix de US$ 0,6354 à US$ 3,1399.

Vor Biopharma compte actuellement 68 673 612 actions en circulation. La capitalisation boursière d'Vor Biopharma est de US$76,23 million. Vor Biopharma a un ratio cours/bénéfice (ratio PE) de -0.64.

VOR Dernières nouvelles

Vor Bio Announces $55.6 Million Private Placement

Intend to announce updated clinical data from Phase 1/2 VBP301 trial of VCAR33ALLO in the first half of 2025 and updated clinical data from Phase 1/2a VBP101 trial of trem-cel in combination with...

Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design

Preliminary data suggests improved relapse-free survival compared to published groups of acute myeloid leukemia (AML) patients at high risk of relapse post-transplantTrem-cel + Mylotarg continue...

Vor Bio to Participate in the Stifel 2024 Healthcare Conference

CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and...

Vor Bio Reports Third Quarter 2024 Financial Results and Provides Company Update

Company to present trem-cel + Mylotarg clinical data update at American Society of Hematology (ASH) 2024 annual meetingHan Choi, M.D., LL.M, seasoned healthcare institutional investor, appointed...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.2427.58620689660.871.350.8224107771.22419856CS
40.219924.70508931580.89011.350.810164001.10592993CS
120.4363.23529411760.681.350.63546565920.95781437CS
260.1313.26530612240.981.350.63547154930.91980269CS
52-1.14-50.66666666672.253.13990.63545229361.18411817CS
156-10.56-90.488431876611.6712.730.63542652322.41841824CS
260-40.91-97.358400761542.0263.620.63542420016.23538325CS

VOR - Frequently Asked Questions (FAQ)

What is the current Vor Biopharma share price?
The current share price of Vor Biopharma is US$ 1,11
How many Vor Biopharma shares are in issue?
Vor Biopharma has 68 673 612 shares in issue
What is the market cap of Vor Biopharma?
The market capitalisation of Vor Biopharma is USD 76,23M
What is the 1 year trading range for Vor Biopharma share price?
Vor Biopharma has traded in the range of US$ 0,6354 to US$ 3,1399 during the past year
What is the PE ratio of Vor Biopharma?
The price to earnings ratio of Vor Biopharma is -0,64
What is the reporting currency for Vor Biopharma?
Vor Biopharma reports financial results in USD
What is the latest annual profit for Vor Biopharma?
The latest annual profit of Vor Biopharma is USD -117,86M
What is the registered address of Vor Biopharma?
The registered address for Vor Biopharma is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Vor Biopharma website address?
The website address for Vor Biopharma is www.vorbio.com
Which industry sector does Vor Biopharma operate in?
Vor Biopharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
AALAmerican Airlines Group Inc
US$ 17,43
(0,00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0,1326
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 69,0184
(0,00%)
0
AADIAadi Bioscience Inc
US$ 3,155
(0,00%)
0
AACGATA Creativity Global
US$ 0,846
(0,00%)
0
AALAmerican Airlines Group Inc
US$ 17,43
(0,00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0,1326
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 69,0184
(0,00%)
0
AADIAadi Bioscience Inc
US$ 3,155
(0,00%)
0
AACGATA Creativity Global
US$ 0,846
(0,00%)
0
AALAmerican Airlines Group Inc
US$ 17,43
(0,00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0,1326
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 69,0184
(0,00%)
0
AADIAadi Bioscience Inc
US$ 3,155
(0,00%)
0
AACGATA Creativity Global
US$ 0,846
(0,00%)
0
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock